Bioline Rx reported $3.87M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Arca Biopharma USD 36.43M 2M Mar/2026
Bio Path USD 297K 191K Mar/2026
Bioline Rx USD 3.87M 386K Jun/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025